Add like
Add dislike
Add to saved papers

Chondrosarcoma of the Scapula in a Patient with Maffucci Syndrome - Case Report and Literature Review.

Maffucci syndrome (MS) is a very rare, non-hereditary dysplasia, manifested by multiple enchondromas and haemangiomas. Malignant transformation of these lesions is seen in up to 33% of the cases. There is also a very rare association with secondary musculoskeletal deformaties. We present a case of a patient with Maffucci syndrome and an associated chondrosarcoma of the scapula. Treatment consisted of surgical resection. Because of the low grade of the tumour (G1), additional treatment radiotherapy/chemotherapy), was not necessary. Maffucci syndrome is an extremely rare mesodermal dysplasia. Malignant transformation of the associated enchondromas is common (33%) and should be considered whenever a change of the clinical course occurs. Clinical, as well as imaging follow-up magnetic resonance imaging (MRI) is required because of the relatively high rate of malignant degeneration of the skeletal lesions. However, random, X-ray examinations give little additional information on malignant transformation and are considered useless.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app